The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review
Author:
Funder
Ludwig Maximillians University Munich
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference87 articles.
1. The journey from discoveries in fundamental immunology to cancer immunotherapy;Miller;Cancer Cell,2015
2. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med.,2016
3. Cancer immunotherapy: harnessing the immune system to battle cancer;Yang;J. Clin. Investig.,2015
4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: a cancer J. Clinicians,2018
5. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition);Zhou;Liver Cancer,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment;Cancer Medicine;2023-04-19
2. A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma;PeerJ;2023-01-06
3. Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma;Cancer Science;2022-12-19
4. Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells;Advanced NanoBiomed Research;2022-10-27
5. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma;Frontiers in Genetics;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3